- Lobbying
- Lobbying by Life Technologies Corporation
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Patricia DeLoatche | Health Policy Director; Sen. Orrin Hatch Chief of Staff; Rep. Mike Bilirakis Legislative Director; Rep. Mike Bilirakis Legislative Assistant; Rep. Mike Bilirakis Legislative Assistant; Rep. Mike Biliraks Healthy Policy Director; Sen. Orrin Hatch Healthy Policy Director, Sen. Orrin Hatch |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q1 Report
Q4 Report
Q3 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Registration
Issue(s) they said they’d lobby about: Policy issues related to regulation of life science research products by FDA.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate